Vita Coco director awarded 1,530 deferred RSUs
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Vita Coco Company, Inc. director Jane Cecil Morreau received an equity grant of 1,530 shares of Common Stock on June 3, 2026, reported as deferred RSUs that will vest in full before the next annual stockholders meeting or on the first anniversary of the grant date, subject to continued board service. Following this grant, she directly holds 18,709 Common shares. She also holds a fully vested, currently exercisable non-qualified stock option covering 30,500 Common shares at an exercise price of $10.178 per share, expiring on July 12, 2031.
Insider Trade Summary
Grant/Award: 1,530 shares
Grant/Award
1 txn
Insider
Morreau Jane Cecil
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,530 | $75.18 | $115K |
| Holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Common Stock — 18,709 shares (Direct);
Non-Qualified Stock Option (Right to Buy) — 30,500 contracts (Direct)
Holdings Before and After:
Common Stock, 17,179 to 18,709 shares (Direct)
Footnotes (2)
- F1. Represents deferred RSUs granted under the Issuers 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on the date the Reporting Person ceases service on the Board. Each deferred RSU represents the right to receive one share of common stock of the Issuer.
- F2. The stock option is fully vested and currently exercisable.
Key Figures
Deferred RSU grant: 1,530 shares
Post-grant common holdings: 18,709 shares
Option exercise price: $10.178/share
+3 more
6 metrics
Deferred RSU grant
1,530 shares
Equity award to director on June 3, 2026
Post-grant common holdings
18,709 shares
Common Stock directly held after transaction
Option exercise price
$10.178/share
Non-qualified stock option on 30,500 underlying shares
Option underlying shares
30,500 shares
Common Stock underlying fully vested option
Option expiration
July 12, 2031
Expiration date of non-qualified stock option
RSU reference price
$75.18/share
Price per share shown for 1,530-share Common Stock grant
Key Terms
Non-Qualified Stock Option (Right to Buy), deferred RSUs, 2021 Incentive Award Plan, vesting, +1 more
5 terms
Non-Qualified Stock Option (Right to Buy) financial
"Non-Qualified Stock Option (Right to Buy) fully vested and currently exercisable"
deferred RSUs financial
"Represents deferred RSUs granted under the Issuers 2021 Incentive Award Plan"
2021 Incentive Award Plan financial
"deferred RSUs granted under the Issuers 2021 Incentive Award Plan which vest in full"
vesting financial
"which vest in full the earlier of the next Annual Stockholders Meeting or first anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Common Stock financial
"Each deferred RSU represents the right to receive one share of common stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Vita Coco (COCO) disclose for Jane Cecil Morreau?
Vita Coco reported that director Jane Cecil Morreau received an equity grant of 1,530 Common shares on June 3, 2026. These are deferred RSUs that vest based on her continued board service and will settle when she leaves the board.
What are the terms of Jane Cecil Morreau’s stock options at Vita Coco (COCO)?
Jane Cecil Morreau holds a fully vested non-qualified stock option to acquire 30,500 Vita Coco Common shares at an exercise price of $10.178 per share. The option is currently exercisable and is scheduled to expire on July 12, 2031.
How do the deferred RSUs granted to Jane Cecil Morreau at Vita Coco (COCO) vest?
The deferred RSUs vest in full on the earlier of the day immediately before the next annual stockholders meeting after grant or the first anniversary of the grant date. Vesting requires that Jane Cecil Morreau remain in continuous board service until that date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
